The Scientist

» clinical trials, disease/medicine and ecology

Most Recent

image: New Down Syndrome Protein Found

New Down Syndrome Protein Found

By | March 26, 2013

Researchers identify a protein involved in the chromosomal disorder that could explain its characteristic learning deficits.

0 Comments

image: Bridges for UK Water Voles

Bridges for UK Water Voles

By | March 20, 2013

Newly constructed ramps will expand the habitat available to a colony of water voles in London, and similar ramps elsewhere could encourage isolated populations to mix.   

0 Comments

image: Anthrax Vax Test OK for Kids

Anthrax Vax Test OK for Kids

By | March 19, 2013

A presidential bioethics commission lays out the framework for testing the anthrax vaccine in children.

0 Comments

image: Opinion: Genomics in the Clinic

Opinion: Genomics in the Clinic

By | March 18, 2013

Next-generation sequencing diagnostics are already being used, and patients are ready.

0 Comments

image: Week in Review

Week in Review

By | March 15, 2013

Disgruntled Nobel loser sues; brain trauma researchers search for biomarker of a chronic condition; receptor for novel coronavirus found; the rise of transcriptomics; and ethical oversight of participant-led research

0 Comments

image: Novel Virus Entry Portal Found

Novel Virus Entry Portal Found

By | March 13, 2013

Researchers identify the target protein of a recently discovered human coronavirus, shedding light on infection and possible interspecies spread.

1 Comment

image: Opinion:  Unconventional Standards

Opinion: Unconventional Standards

By | March 13, 2013

Tailoring ethical oversight to participant-led research

2 Comments

image: Native Frogs Beat Invasive Toads

Native Frogs Beat Invasive Toads

By | March 8, 2013

Native Australian frog tadpoles outcompete the tadpoles of the invasive cane toad, suggesting the native frogs could form part of a suburban control program.

0 Comments

image: FDA Reform to Boost US Economy?

FDA Reform to Boost US Economy?

By | March 5, 2013

Two experts propose replacing Phase 3 trials with smaller, faster alternatives and post-market surveillance to invigorate the pharmaceutical industry.

0 Comments

image: Networking Medicine

Networking Medicine

By | March 2, 2013

Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.

0 Comments

Popular Now

  1. Unstructured Proteins Help Tardigrades Survive Desiccation
  2. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  3. Opinion: On “The Impact Factor Fallacy”
  4. Inflammation Drives Gut Bacteria Evolution
Business Birmingham